In analogy to skin CD8+ T cells, the CD49a-expressing ILC1s might also protect brain parenchyma from AD and viral or bacterial infections by promoting the persistence of CD8+ cells within the CNS. This evidence concerns the gene CD8A and Alzheimer disease.